| NCT ID | NCT07598227 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Buddhist Tzu Chi General Hospital |
| Condition | Nocturia |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-01-01 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2025-01-01 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Nocturia, the interruption of sleep due to nighttime voiding, severely compromises quality of life, emotional health, and overall well-being when occurring twice or more per night. Given that some patients experience inadequate responses to conventional Western therapies or harbor concerns about the long-term side effects of pharmaceuticals, many are turning to Traditional Chinese Medicine (TCM) for alternative solutions. This study utilized a randomized clinical trial design to investigate the efficacy and safety of acupoint moxibustion for nocturia.
Eligibility Criteria
Inclusion Criteria: * Patients aged 40 years or older. * Experiencing two or more nocturia episodes per night. Exclusion Criteria * Active urinary tract infection (UTI). * Poorly controlled diabetes mellitus (defined as HbA1c \> 6.5%). * Presence of a neurogenic bladder caused by conditions such as multiple sclerosis, Parkinson's disease, stroke, spinal cord injury, or nerve damage resulting from major pelvic surgery. * Severe congestive heart failure (New York Heart Association \[NYHA\] functional class \> II). * Use of other Traditional Chinese Medicine (TCM) therapies for nocturia symptoms within the past month (30 days). * Pregnant women.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07598227 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, studying Nocturia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07598227 currently recruiting?
Yes, NCT07598227 is actively recruiting participants. Contact the research team at kung818@gmail.com for enrollment information.
Where is the NCT07598227 trial being conducted?
This trial is being conducted at Hualien City, Taiwan.
Who is sponsoring the NCT07598227 clinical trial?
NCT07598227 is sponsored by Buddhist Tzu Chi General Hospital. The trial plans to enroll 100 participants.